Global Angio Suites Market - 2022-2029

Market Overview

The Angio Suites Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 5% during the forecast period (2022-2029).

Angio suites are well-resourced, multipurpose areas used to carry out interventional vascular procedures. These facilities carry out several medical treatments, including minimally invasive endovascular surgery, ischemic stroke treatment, myelograms, aortic dissection, ruptured aneurysms, diagnostic imaging techniques, and medical imaging practices. The Angio suites' adaptability is a real asset because it allows for the execution of numerous medical operations. Angio suites offer a one-stop solution to patients, reducing the real trauma of the surgery by eliminating the need for patients to transition between various operating rooms.

Market Dynamics

Technological advancement in the CT Systems for Precision therapy in interventional oncology is expected to drive market growth.

Interventional radiology greatly benefits from combined angiography-CT (angio-CT) systems, which combine standard angiographic imaging with cross-sectional imaging. Although flat-panel angiography systems' cone-beam CT (CBCT) technology has long been used as an adjunct cross-sectional imaging tool during interventional procedures, the inherent benefits of angio-CT systems' superior soft-tissue imaging and contrast resolution, as well as their ease of operation, have reignited interest in their application to interventional oncology procedures. Angio-CT systems have emerged as a competitive alternative to standalone flat-panel angiographic systems with CBCT due to gains in pricing and usability brought on by improved workflow. Additionally, cross-sectional imaging from the CT scanner and fluoroscopic imaging from the angiography system are combined to more precisely plan oncologic interventions, combine multiple therapies in one location, and track intraprocedural treatment responses, minimizing complications and enhancing therapeutic outcomes. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

High costs associated with arranging angio suites, lacking skilled personnel who are proficient at using angio suites and increasing usage of reconditioned diagnostic imaging equipment, and significant radiation exposure risk are some of the factors the market is expected to hamper in the forecast period.

Industry Analysis

The angio suites market provides in-depth analysis of the market based on various industry factors such as porter's five forces, supply chain analysis, reimbursement scenario, product innovation, pricing analysis, etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. Heart disease and other chronic disease cases increased during the pandemic while the coronavirus was active. Because angio suites are the cutting-edge interventions used for precise and effective diagnosis that aid in visualizing the interior of human blood vessels, particularly the arteries, demand for them has skyrocketed. The abrupt and uncontrolled rise in COVID-19 cases led to a surge in patients with heart disease, raising the need for modern angio suites. The Centers for Disease Control and Prevention suggested postponing elective cardiac procedures, such as coronary angiography and percutaneous coronary intervention for stable coronary artery disease, to conserve resources, including personal protective equipment and hospital beds to care for COVID-19 patients. During the early stages of the COVID epidemic, it is predicted that STEMI activations in cardiac catheterization laboratories in the United States decreased by 38%, matching the 40% reduction seen in Spain.

Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Angioplasty segment is expected to hold the largest market share in angio suites market

The angioplasty segment is expected to dominate in 2021. The segment is beneficial because angioplasty is a procedure used to open coronary arteries that have become blocked due to coronary artery disease. Additionally, angioplasty has fewer scars, lessens post-operative side effects, a greater success rate, low invasion, and quick recovery. Additionally, as the burden of coronary heart disease rises, the demand for angioplasty increases since it can be used to enlarge blocked or restricted coronary arteries, keeping the patient safe. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global angio suites market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of cardiovascular diseases, rising investments in research & development, increasing high-quality medical facilities, including hospitals and laboratories, high level of awareness of healing difficulties and the availability of effective treatments and product launches and acquisitions by the key market players are some of the factors the market is expected to boost in the forecast period. For instance, In the United States, heart disease is the leading cause of death for both sexes and members of most racial and ethnic groups. Cardiovascular disease claims one life in the United States every 36 seconds. One in four deaths in the US is caused by heart disease, which affects about 659,000 people annually. Moreover, according to the American Heart Association, in 2019, at least 48 percent of adults in the United States suffer from cardiovascular disease.

Additionally, a subsidiary of renowned Massachusetts-based firm General Electric, GE Healthcare, announced the successful acquisition of Boston, Massachusetts-based imaging company "BK Medical" on December 21, 2021. The deal has been completed with a $1.45 billion payment from GE. Furthermore, the deal has helped GE Healthcare's ultrasound division grow. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the angio suites market are Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare, Carestream Health, Canon Medical Systems Corporation, Shimadzu Corp, 3D Systems, IMRIS.

3D Systems:

Overview:

A 3D printing service is provided by 3D Systems, a business with its main office in Rock Hill, South Carolina, which also designs, produces, and sells 3D printers, 3D printing supplies, and 3D scanners. The business produces master patterns for tooling, functional prototypes, production parts for direct digital manufacturing, and concept models for new product ideas. Input from computer-aided design and manufacturing software, 3D scanning, and 3D sculpting tools is used to produce real products utilizing proprietary techniques. Numerous industries, including aerospace, automotive, healthcare, dental, entertainment, and the creation of durable goods, employ the technologies and services provided by 3D Systems. The business provides a selection of 3D printers suitable for professional and industrial use, software, materials, and an online service for producing quick parts.

Product Portfolio:

Simulator-Angio-Mentor: ANGIO Mentor simulators provide multi-specialty hands-on practice of endovascular interventions in an extensive simulated clinical environment of a cath lab, interventional suite or a hybrid operating room. It provides a complete individual and team training solutions to learners of all levels.

The global angio suites market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.